The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Africa has seen a sharp rise in public health events, increasing from 152 in 2022 to 213 in 2024, highlighting ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

THE Catholic Church has suspended the use of holy water as part of its liturgy in efforts to stop the spread of the Mpox ...

The World Health Organization (WHO) injects fresh support into Democratic Republic (DR) of Congo vaccination drive ...

SIGA Technologies Inc (SIGA) reports a robust financial performance with significant international sales and strategic ...

The Africa Centres for Disease Control and Prevention said the country saw a 31 per cent increase in cases last week.